Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

JNC 7: brief summary and critique.

Michael H Alderman1

  • 1Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York 10461, USA. alderman@aecom.yu.edu

Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|February 11, 2005
PubMed
Summary

The 2003 Joint National Committee 7 (JNC 7) guidelines offer updated hypertension management recommendations. This critique examines the JNC 7 report, considering its development process and clinical implications for treating high blood pressure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salt Substitute and Cardiovascular Events and Death.

The New England journal of medicine·2021
Same author

Prediabetes: an unexplored cardiovascular disease risk factor.

Journal of hypertension·2020
Same author

Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake.

European heart journal·2020
Same author

Hypertension: evolving from standardized to individualized care.

Journal of hypertension·2020
Same author

Urinary sodium excretion measures and health outcomes.

Lancet (London, England)·2019
Same author

Can We End the Salt Wars With a Randomized Clinical Trial in a Controlled Environment?

Hypertension (Dallas, Tex. : 1979)·2018

Area of Science:

  • Cardiology
  • Hypertension Management
  • Clinical Guidelines

Background:

  • Recent publication of updated hypertension guidelines by major European and US organizations.
  • The need for timely, evidence-based recommendations for managing arterial hypertension.
  • The challenges in developing consensus guidelines amidst complex evidence and expert opinions.

Purpose of the Study:

  • To provide a selective summary and critique of the 2003 Joint National Committee 7 (JNC 7) report.
  • To evaluate the JNC 7 guidelines for the prevention, detection, evaluation, and treatment of high blood pressure.
  • To stimulate dialogue regarding the JNC 7 document and its impact on clinical practice.

Main Methods:

  • Review and analysis of the published JNC 7 report.

Related Experiment Videos

  • Assessment of the JNC 7 guideline development process, including timeline, author composition, and conflict of interest disclosures.
  • Critical evaluation of the JNC 7's approach to evidence rating and therapeutic recommendations.

    • Main Results:

    • The JNC 7 report was developed rapidly (5 months) by a dedicated writing group and reviewed by numerous experts.
    • The writing group disclosed potential financial conflicts and operated without commercial support.
    • The JNC 7 guidelines emphasize simplicity, brevity, and the paramount importance of physician judgment in patient management.

    Conclusions:

    • The JNC 7 report represents a timely update to hypertension management strategies.
    • The guideline development process adhered to principles of transparency and scientific rigor.
    • The JNC 7 aims to provide practical tools, including a therapeutic algorithm, for physicians treating high blood pressure.